These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20156000)

  • 1. Reducing patient harm with the use of fentanyl transdermal system.
    Grissinger M; Gaunt MJ
    Consult Pharm; 2009 Dec; 24(12):864-72. PubMed ID: 20156000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.
    Kornick CA; Santiago-Palma J; Moryl N; Payne R; Obbens EA
    Drug Saf; 2003; 26(13):951-73. PubMed ID: 14583070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicians' knowledge of transdermal fentanyl.
    Welsh J; Reid A; Graham J; Curto J; MacLeod K; O'Neill C
    Palliat Med; 2005 Jan; 19(1):9-16. PubMed ID: 15690863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy.
    Ripamonti C; Fagnoni E; Campa T; Brunelli C; De Conno F
    Support Care Cancer; 2006 May; 14(5):400-7. PubMed ID: 16485087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal fentanyl in opioid-naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine.
    Vielvoye-Kerkmeer AP; Mattern C; Uitendaal MP
    J Pain Symptom Manage; 2000 Mar; 19(3):185-92. PubMed ID: 10760623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
    Tawfik MO; Bryuzgin V; Kourteva G;
    Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pitfall to avoid when starting a patient on transdermal fentanyl.
    Low JA; Chye R
    Aust Fam Physician; 2000 Dec; 29(12):1173-5. PubMed ID: 11140227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based study of transdermal fentanyl initiation in Australian clinical practice.
    Gisev N; Pearson SA; Larance B; Larney S; Blanch B; Degenhardt L
    Eur J Clin Pharmacol; 2019 Mar; 75(3):401-408. PubMed ID: 30392109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication errors related to transdermal opioid patches: lessons from a regional incident reporting system.
    Lövborg H; Holmlund M; Hägg S
    BMC Pharmacol Toxicol; 2014 Jun; 15():31. PubMed ID: 24912424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Converting to transdermal fentanyl: avoidance of underdosing.
    Bradley AM; Valgus JM; Bernard S
    J Palliat Med; 2013 Apr; 16(4):409-11. PubMed ID: 23477303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.
    Muijsers RB; Wagstaff AJ
    Drugs; 2001; 61(15):2289-307. PubMed ID: 11772140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sticking to the safe side with fentanyl patches.
    D'Arcy Y
    Nursing; 2009 Mar; 39(3):62-3. PubMed ID: 19247136
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids.
    Mystakidou K; Befon S; Tsilika E; Dardoufas K; Georgaki S; Vlahos L
    Oncology; 2002; 62(1):9-16. PubMed ID: 11810038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In brief: heat and transdermal fentanyl.
    Med Lett Drugs Ther; 2009 Aug; 51(1318):64. PubMed ID: 19661852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients.
    Radbruch L; Sabatowski R; Petzke F; Brunsch-Radbruch A; Grond S; Lehmann KA
    Palliat Med; 2001 Jul; 15(4):309-21. PubMed ID: 12054148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Initiation of Long-Acting Opioids in Long-Stay Nursing Home Residents.
    Pimentel CB; Gurwitz JH; Tjia J; Hume AL; Lapane KL
    J Am Geriatr Soc; 2016 Sep; 64(9):1772-8. PubMed ID: 27487158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of transdermal fentanyl patches in the effective management of cancer pain.
    Gibbs M
    Int J Palliat Nurs; 2009 Jul; 15(7):354-9. PubMed ID: 19648851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' knowledge of transdermal fentanyl.
    McGregor A
    Palliat Med; 2005 Oct; 19(7):566; author reply 567-8. PubMed ID: 16295291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.